Literature DB >> 16506195

The role of early lineage in GABAergic and glutamatergic cell fate determination in Xenopus laevis.

Mei Li1, Conor W Sipe, Kristina Hoke, Lisa L August, Melissa A Wright, Margaret S Saha.   

Abstract

Proper functioning of the adult nervous system is critically dependent on neurons adopting the correct neurotransmitter phenotype during early development. Whereas the importance of cell-cell communication in fate determination is well documented for a number of neurotransmitter phenotypes, the contributions made by early lineage to this process remain less clear. This is particularly true for gamma-aminobutyric acid (GABA)ergic and glutamatergic neurons, which are present as the most abundant inhibitory and excitatory neurons, respectively, in the central nervous system of all vertebrates. In the present study, we have investigated the role of early lineage in the determination of these two neurotransmitter phenotypes by constructing a fate map of GABAergic and glutamatergic neurons for the 32-cell stage Xenopus embryo with the goal of determining whether early lineage influences the acquisition of these two neurotransmitter phenotypes. To examine these phenotypes, we have cloned xGAT-1, a molecular marker for the GABAergic phenotype in Xenopus, and described its expression pattern over the course of development. Although we have identified isolated examples of a blastomere imparting a statistically significant bias, when taken together, our results suggest that blastomere lineage does not impart a widespread bias for subsequent GABAergic or glutamatergic fate determination. In addition, the fate map presented here suggests a general dorsal-anterior to ventral-posterior patterning progression of the nervous system for the 32-cell stage Xenopus embryo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506195     DOI: 10.1002/cne.20900

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  7 in total

1.  Characterization of tweety gene (ttyh1-3) expression in Xenopus laevis during embryonic development.

Authors:  Andrew D Halleran; Morgan Sehdev; Brian A Rabe; Ryan W Huyck; Cheyenne C Williams; Margaret S Saha
Journal:  Gene Expr Patterns       Date:  2014-12-23       Impact factor: 1.224

2.  Methylmercury exposure during early Xenopus laevis development affects cell proliferation and death but not neural progenitor specification.

Authors:  Ryan W Huyck; Maitreyi Nagarkar; Nina Olsen; Samuel E Clamons; Margaret S Saha
Journal:  Neurotoxicol Teratol       Date:  2014-12-10       Impact factor: 3.763

3.  Epigenetic regulation of GABAergic differentiation in the developing brain.

Authors:  Juanmei Gao; Yuhao Luo; Yufang Lu; Xiaohua Wu; Peiyao Chen; Xinyu Zhang; Lu Han; Mengsheng Qiu; Wanhua Shen
Journal:  Front Cell Neurosci       Date:  2022-09-23       Impact factor: 6.147

4.  Ptf1a triggers GABAergic neuronal cell fates in the retina.

Authors:  Jean-Philippe Dullin; Morgane Locker; Mélodie Robach; Kristine A Henningfeld; Karine Parain; Solomon Afelik; Tomas Pieler; Muriel Perron
Journal:  BMC Dev Biol       Date:  2007-10-02       Impact factor: 1.978

5.  Ascl1 as a novel player in the Ptf1a transcriptional network for GABAergic cell specification in the retina.

Authors:  Nicolas Mazurier; Karine Parain; Damien Parlier; Silvia Pretto; Johanna Hamdache; Philippe Vernier; Morgane Locker; Eric Bellefroid; Muriel Perron
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

6.  The role of voltage-gated calcium channels in neurotransmitter phenotype specification: Coexpression and functional analysis in Xenopus laevis.

Authors:  Brittany B Lewis; Lauren E Miller; Wendy A Herbst; Margaret S Saha
Journal:  J Comp Neurol       Date:  2014-04-12       Impact factor: 3.215

7.  Prdm13 forms a feedback loop with Ptf1a and is required for glycinergic amacrine cell genesis in the Xenopus Retina.

Authors:  Nathalie Bessodes; Karine Parain; Odile Bronchain; Eric J Bellefroid; Muriel Perron
Journal:  Neural Dev       Date:  2017-09-01       Impact factor: 3.842

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.